Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisAntigens, CD34Combined Modality TherapyHematologic NeoplasmsStem Cell TransplantationBlood Component RemovalMultiple MyelomaCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsLeukocytes, MononuclearStem CellsHematopoietic Stem CellsMyeloablative AgonistsGraft vs Host DiseaseBusulfanTreatment OutcomeLymphoma, Non-HodgkinBone Marrow TransplantationGraft SurvivalEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyHematopoiesisVincristineAmyloidosisCytarabineCord Blood Stem Cell TransplantationHodgkin DiseaseDisease-Free SurvivalTransplantation ChimeraNeoplasmsRetrospective StudiesTissue DonorsTime FactorsSurvival RateWhole-Body IrradiationInfectionLymphoma, T-CellSurvival AnalysisDoxorubicinHistocompatibilityPlatelet CountPOEMS SyndromeImmunosuppressive AgentsHistocompatibility TestingRecombinant ProteinsBlood CellsT-LymphocytesPrednisoneCells, CulturedCarboplatinLeukemia, Myeloid, AcuteDexamethasoneBlood Cell CountTransplantation, IsogeneicLeukemiaVidarabineFlow CytometryFollow-Up StudiesAdipose TissueAntineoplastic AgentsImmunophenotypingLymphomaCytomegalovirus InfectionsBone Marrow PurgingProspective StudiesEmbryonic Stem CellsGraft vs Leukemia EffectFatal OutcomeFeasibility StudiesCell SeparationLymphocytesAdult Stem CellsAntigens, CDMesenchymal Stem Cell TransplantationLymphocyte ActivationAnemia, AplasticBone MarrowMyelodysplastic SyndromesCell DifferentiationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionHLA AntigensBlood Transfusion, AutologousLiver TransplantationBlood Donors